IOL Chemicals & Pharmaceuticals Intrinsic Value
IOLCP • Healthcare
Current Stock Price
₹78.60
Primary Intrinsic Value
₹89.76
Market Cap
₹463.7 Cr
+100.0%
Upside
Median Value
₹157.20
Value Range
₹26 - ₹197
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
IOLCP Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹89.76 | ₹71.81 - ₹107.71 | +14.2% | EPS: ₹4.08, Sector P/E: 22x |
| Book Value Method | asset | ₹196.50 | ₹176.85 - ₹216.15 | +150.0% | Book Value/Share: ₹286.10, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹157.20 | ₹141.48 - ₹172.92 | +100.0% | Revenue/Share: ₹389.15, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹157.20 | ₹141.48 - ₹172.92 | +100.0% | EBITDA: ₹256.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹196.50 | ₹157.20 - ₹235.80 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹26.11 | ₹23.50 - ₹28.72 | -66.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹63.04 | ₹56.74 - ₹69.34 | -19.8% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹157.20 | ₹141.48 - ₹172.92 | +100.0% | ROE: 7.1%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹162.06 | ₹145.85 - ₹178.27 | +106.2% | EPS: ₹4.08, BVPS: ₹286.10 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
IOLCP Intrinsic Value Analysis
What is the intrinsic value of IOLCP?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of IOL Chemicals & Pharmaceuticals (IOLCP) is ₹157.20 (median value). With the current market price of ₹78.60, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹26.11 to ₹196.50, indicating ₹26.11 - ₹196.50.
Is IOLCP undervalued or overvalued?
Based on our multi-method analysis, IOL Chemicals & Pharmaceuticals (IOLCP) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 13.54 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 7.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 10.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.96x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for IOL Chemicals & Pharmaceuticals
Additional stock information and data for IOLCP
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹179 Cr | ₹102 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹290 Cr | ₹195 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹122 Cr | ₹62 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹93 Cr | ₹33 Cr | Positive Free Cash Flow | 7/10 |